A detailed history of Group One Trading, L.P. transactions in Novavax Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 30,610 shares of NVAX stock, worth $246,716. This represents 0.02% of its overall portfolio holdings.

Number of Shares
30,610
Previous 169,754 81.97%
Holding current value
$246,716
Previous $2.15 Million 82.04%
% of portfolio
0.02%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.71 - $17.11 $1.49 Million - $2.38 Million
-139,144 Reduced 81.97%
30,610 $386,000
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $660,343 - $3.56 Million
169,754 New
169,754 $2.15 Million
Q2 2022

Aug 11, 2022

SELL
$36.28 - $75.29 $406,662 - $843,925
-11,209 Reduced 5.63%
188,061 $9.67 Million
Q1 2022

May 12, 2022

BUY
$69.73 - $142.9 $6.89 Million - $14.1 Million
98,798 Added 98.33%
199,270 $14.7 Million
Q4 2021

Feb 11, 2022

BUY
$134.56 - $217.97 $4.25 Million - $6.89 Million
31,603 Added 45.89%
100,472 $14.4 Million
Q3 2021

Nov 12, 2021

SELL
$177.8 - $270.58 $8.97 Million - $13.7 Million
-50,474 Reduced 42.29%
68,869 $14.3 Million
Q2 2021

Aug 10, 2021

BUY
$121.0 - $257.67 $9.1 Million - $19.4 Million
75,171 Added 170.18%
119,343 $25.3 Million
Q1 2021

May 12, 2021

BUY
$112.98 - $319.93 $4.2 Million - $11.9 Million
37,213 Added 534.75%
44,172 $8.01 Million
Q4 2020

Feb 10, 2021

SELL
$78.74 - $139.5 $2.64 Million - $4.67 Million
-33,480 Reduced 82.79%
6,959 $776,000
Q3 2020

Nov 12, 2020

SELL
$79.44 - $178.51 $1.85 Million - $4.16 Million
-23,325 Reduced 36.58%
40,439 $4.38 Million
Q2 2020

Aug 13, 2020

BUY
$13.86 - $83.61 $879,708 - $5.31 Million
63,471 Added 21662.46%
63,764 $5.32 Million
Q1 2020

May 13, 2020

SELL
$3.93 - $16.0 $251,948 - $1.03 Million
-64,109 Reduced 99.55%
293 $4,000
Q4 2019

Feb 10, 2020

BUY
$3.69 - $5.22 $237,643 - $336,178
64,402 New
64,402 $256,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.